{"pmid":32484906,"title":"Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in beta-Thalassemias: The Nationwide Iranian Experience.","text":["Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in beta-Thalassemias: The Nationwide Iranian Experience.","In late December 2019, an ongoing outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that was termed Coronavirus Disease 2019 (COVID-19), was reported in Wuhan, China (Zhu, et al 2020).","Br J Haematol","Karimi, Mehran","Haghpanah, Sezaneh","Azarkeivan, Azita","Zahedi, Zohreh","Zarei, Tahereh","Akhavan Tavakoli, Maryam","Bazrafshan, Asghar","Shirkavand, Afshan","De Sanctis, Vincezo","32484906"],"abstract":["In late December 2019, an ongoing outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that was termed Coronavirus Disease 2019 (COVID-19), was reported in Wuhan, China (Zhu, et al 2020)."],"journal":"Br J Haematol","authors":["Karimi, Mehran","Haghpanah, Sezaneh","Azarkeivan, Azita","Zahedi, Zohreh","Zarei, Tahereh","Akhavan Tavakoli, Maryam","Bazrafshan, Asghar","Shirkavand, Afshan","De Sanctis, Vincezo"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484906","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/bjh.16911","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668704334429290496,"score":9.490897,"similar":[{"pmid":32447232,"title":"COVID-19: beta-thalassemia subjects immunised?","text":["COVID-19: beta-thalassemia subjects immunised?","The novel coronavirus pneumonia (COVID-19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent PRE-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia results of a default in the hemoglobin beta-chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research.","Med Hypotheses","Lansiaux, Edouard","Pebay, Philippe Pierre","Picard, Jean-Laurent","Son-Forget, Joachim","32447232"],"abstract":["The novel coronavirus pneumonia (COVID-19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent PRE-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia results of a default in the hemoglobin beta-chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research."],"journal":"Med Hypotheses","authors":["Lansiaux, Edouard","Pebay, Philippe Pierre","Picard, Jean-Laurent","Son-Forget, Joachim"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447232","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.mehy.2020.109827","keywords":["beta thalassemia","correlation","favipiravir","heme","immunization","italy","novel coronavirus","regression","respiratory distress","sardinia","statistics"],"locations":["Italian","Sardinia","Sicilia"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667698385854922754,"score":97.63318},{"pmid":32311181,"title":"SARS-CoV-2: What Can Saliva Tell Us?","text":["SARS-CoV-2: What Can Saliva Tell Us?","An epidemic pneumonia was first reported in the city of Wuhan, China, in the end of December 2019, had its aetiological agent identified as a new coronavirus (Zhu et al., 2020). The World Health Organisation (WHO) declared on 11 March 2020 that the epidemic of the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic now called COVID-19.","Oral Dis","Braz-Silva, Paulo Henrique","Pallos, Debora","Giannecchini, Simone","To, Kelvin Kai-Wang","32311181"],"abstract":["An epidemic pneumonia was first reported in the city of Wuhan, China, in the end of December 2019, had its aetiological agent identified as a new coronavirus (Zhu et al., 2020). The World Health Organisation (WHO) declared on 11 March 2020 that the epidemic of the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic now called COVID-19."],"journal":"Oral Dis","authors":["Braz-Silva, Paulo Henrique","Pallos, Debora","Giannecchini, Simone","To, Kelvin Kai-Wang"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311181","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/odi.13365","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491135721472,"score":95.679726},{"pmid":32425004,"title":"Clinical value of the emergency department in screening and diagnosis of COVID-19 in China.","text":["Clinical value of the emergency department in screening and diagnosis of COVID-19 in China.","Since the global outbreak of severe acute respiratory syndrome (SARS) in 2003, China has gradually built a robust prevention and control system for sudden infectious diseases. All large hospitals have a fever clinic that isolates patients with all kinds of acute communicable diseases as the first line of medical defense. The emergency department, as the second line of medical defense in hospitals, is constantly shouldering the heavy responsibility of screening communicable diseases while also treating all kinds of other non-communicable acute and critical diseases (Zhang et al., 2012; Zhu et al., 2015; Wang et al., 2017; Feng et al., 2018; Lu, 2018; Xu and Lu, 2019). An outbreak of pneumonia of unknown etiology that began in Wuhan city (China) has spread rapidly in China since December 2019 (Huang et al., 2020; WHO, 2020; Zhu et al., 2020). In February 2020, the National Health Commission of China named the disease a novel coronavirus pneumonia (NCP); then, it was formally named the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO) on Feb. 11, 2020. The Coronavirus Study Group of the International Committee on Taxonomy of Viruses designated this causative virus as SARS coronavirus 2 (SARS-CoV-2). SARS-CoV-2 belongs to the beta coronavirus genus, and its pathogenic mechanism has not been clarified, which requires further study. To better understand the clinical characteristics of COVID-19 and more effectively prevent and control this disease, we retrospectively analyzed four representative cases of COVID-19 that had recently been screened and diagnosed in our emergency department.","J Zhejiang Univ Sci B","Zhang, Qin","Pan, Jian","Zhao, Min-Xing","Lu, Yuan-Qiang","32425004"],"abstract":["Since the global outbreak of severe acute respiratory syndrome (SARS) in 2003, China has gradually built a robust prevention and control system for sudden infectious diseases. All large hospitals have a fever clinic that isolates patients with all kinds of acute communicable diseases as the first line of medical defense. The emergency department, as the second line of medical defense in hospitals, is constantly shouldering the heavy responsibility of screening communicable diseases while also treating all kinds of other non-communicable acute and critical diseases (Zhang et al., 2012; Zhu et al., 2015; Wang et al., 2017; Feng et al., 2018; Lu, 2018; Xu and Lu, 2019). An outbreak of pneumonia of unknown etiology that began in Wuhan city (China) has spread rapidly in China since December 2019 (Huang et al., 2020; WHO, 2020; Zhu et al., 2020). In February 2020, the National Health Commission of China named the disease a novel coronavirus pneumonia (NCP); then, it was formally named the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO) on Feb. 11, 2020. The Coronavirus Study Group of the International Committee on Taxonomy of Viruses designated this causative virus as SARS coronavirus 2 (SARS-CoV-2). SARS-CoV-2 belongs to the beta coronavirus genus, and its pathogenic mechanism has not been clarified, which requires further study. To better understand the clinical characteristics of COVID-19 and more effectively prevent and control this disease, we retrospectively analyzed four representative cases of COVID-19 that had recently been screened and diagnosed in our emergency department."],"journal":"J Zhejiang Univ Sci B","authors":["Zhang, Qin","Pan, Jian","Zhao, Min-Xing","Lu, Yuan-Qiang"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425004","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1631/jzus.B2010011","keywords":["coronavirus disease 2019 (covid-19); sars-cov-2; emergency department"],"locations":["China","Wuhan","China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1667352728908595201,"score":87.22046},{"pmid":32311145,"title":"SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.","text":["SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.","Am J Hematol","Motta, Irene","Migone De Amicis, Margherita","Pinto, Valeria M","Balocco, Manuela","Longo, Filomena","Bonetti, Federico","Gianesin, Barbara","Graziadei, Giovanna","Cappellini, Maria D","De Franceschi, Lucia","Piga, Antonio","Forni, Gian L","32311145"],"journal":"Am J Hematol","authors":["Motta, Irene","Migone De Amicis, Margherita","Pinto, Valeria M","Balocco, Manuela","Longo, Filomena","Bonetti, Federico","Gianesin, Barbara","Graziadei, Giovanna","Cappellini, Maria D","De Franceschi, Lucia","Piga, Antonio","Forni, Gian L"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311145","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ajh.25840","locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138491223801861,"score":83.90235},{"pmid":32292261,"pmcid":"PMC7144605","title":"Biological and Epidemiological Trends in the Prevalence and Mortality due to Outbreaks of Novel Coronavirus COVID-19.","text":["Biological and Epidemiological Trends in the Prevalence and Mortality due to Outbreaks of Novel Coronavirus COVID-19.","The novel coronavirus (Covid-19) infection outbreak has posed a major threat to international health system and economy. This study is aimed at investigating the biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus (COVID-19) infections. The data on the global outbreak of COVID-19, were obtained from World Health Organization (WHO), Worldometer, Centers for Disease Control and Prevention (CDC), and research institutes. The information was also recorded from research documents published in global scientific journals indexed in Pub Med and Institute of Scientific Information (ISI) Web of Science on the trends in the prevalence and mortality due to COVID-19 infection outbreaks. The results show rising trends in the transmission, prevalence and mortality rate due to coronavirus COVID-19. During the period of December 29, 2019 through March 31, 2020, it has infected 750890 people worldwide, resulting in 36405 deaths with a mortality rate of 4.84%. The infections were more frequent among male gender with above 60 years of age. The mean growth rate index for total number of cases from January 23 to March 31, 2020 was 1.20 and growth rate index for mortality rate was 1.12. There was a positive association between the prevalence and mortality rate (R(2)=0.996). The novel coronavirus COVID-19 is highly contagious and has affected a large number of people worldwide. It is still spreading with mutable prevalence and mortality outbreak trends. The global health officials have taken priority measures to prevent the further outbreaks of this emerging pathogen across the globe. However, the rising number of cases and mortality risk estimates are demonstrating that enhanced public health mediations, good hygienic conditions, social distancing and movement limitations may control the COVID-19 epidemics.","J King Saud Univ Sci","Meo, Sultan Ayoub","Al-Khlaiwi, Thamir","Usmani, Adnan Mahmood","Meo, Anusha Sultan","Klonoff, David C","Hoang, Thanh D","32292261"],"abstract":["The novel coronavirus (Covid-19) infection outbreak has posed a major threat to international health system and economy. This study is aimed at investigating the biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus (COVID-19) infections. The data on the global outbreak of COVID-19, were obtained from World Health Organization (WHO), Worldometer, Centers for Disease Control and Prevention (CDC), and research institutes. The information was also recorded from research documents published in global scientific journals indexed in Pub Med and Institute of Scientific Information (ISI) Web of Science on the trends in the prevalence and mortality due to COVID-19 infection outbreaks. The results show rising trends in the transmission, prevalence and mortality rate due to coronavirus COVID-19. During the period of December 29, 2019 through March 31, 2020, it has infected 750890 people worldwide, resulting in 36405 deaths with a mortality rate of 4.84%. The infections were more frequent among male gender with above 60 years of age. The mean growth rate index for total number of cases from January 23 to March 31, 2020 was 1.20 and growth rate index for mortality rate was 1.12. There was a positive association between the prevalence and mortality rate (R(2)=0.996). The novel coronavirus COVID-19 is highly contagious and has affected a large number of people worldwide. It is still spreading with mutable prevalence and mortality outbreak trends. The global health officials have taken priority measures to prevent the further outbreaks of this emerging pathogen across the globe. However, the rising number of cases and mortality risk estimates are demonstrating that enhanced public health mediations, good hygienic conditions, social distancing and movement limitations may control the COVID-19 epidemics."],"journal":"J King Saud Univ Sci","authors":["Meo, Sultan Ayoub","Al-Khlaiwi, Thamir","Usmani, Adnan Mahmood","Meo, Anusha Sultan","Klonoff, David C","Hoang, Thanh D"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292261","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jksus.2020.04.004","keywords":["2019-ncov","biological trends","coronavirus","covid-2019","outbreak","prevalence"],"topics":["Prevention"],"weight":1,"_version_":1666138494359044097,"score":80.81733}]}